MedTrace Logo

Collaborative Research on HFR High Flux

NCT01492491 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-06-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the serum concentrations of antoxidant vitamines A, C, E, inflammatory cytokines and middle-large toxins in patients treated with online hemodiafiltration, standard HFR and SUPRA-HFR.

Conditions

Interventions

DEVICE

SUPRA-HFR

usual dialytic prescription for duration, frequency, acid buffer and anticoagulation regimen.

Sponsors & Collaborators

  • Bellco s.r.l.

    collaborator UNKNOWN

  • Istituto Superiore di Sanità

    collaborator OTHER

  • Azienda Sanitaria Locale di Cagliari

    lead OTHER

Principal Investigators

  • Piergiorgio Bolasco, MD · Azienda Sanitaria Locale di Cagliari

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-12-31
Completion
2013-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01492491 on ClinicalTrials.gov